Frazier Management LLC Gritstone Bio, Inc. Transaction History

Frazier Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.03 - $12.19 $18.8 Million - $56.9 Million	-4,667,242 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.41 - $13.54 $23.3 Million - $49.2 Million	3,636,364 Added 352.74%	4,667,242 $50.4 Million
Q1 2021 May 12, 2021	SELL	$4.07 - $27.11 $4.2 Million - $27.9 Million	-1,030,880 Reduced 50.0%	1,030,878 $9.72 Million
Q4 2018 Feb 11, 2019	SELL	$11.61 - $31.1 $46 - $124	-4 Reduced -0.0%	2,061,758 $31.9 Million
Q3 2018 Nov 14, 2018	BUY	$14.24 - $14.24 $29.4 Million - $29.4 Million	2,061,762 New	2,061,762 $29.4 Million

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.